“Stability Indicating RP-UPLC Method Development & Validation for Quantitation of Doravirine in Tablet Formulation ”, Journal of Pharmaceutical Negative Results, vol. 13, no. 4, pp. 1776–1782, Jan. 2023, doi: 10.47750/pnr.2022.13.04.243.